Metabolic outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir/lamivudine in treatment-naïve people living with HIV: a 48-week retrospective studyYifan Guo, Hongxin Zhao, Yi-Xiang Wang et al.|Expert Review of Anti-infective Therapy|2026Cited by 0